Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12226
CALL
VEON
VEON
$3.93B
| $56.1K | ﹤0.01% |
1,400
-2,700
| -66% | -$89.6K |
|
12227
CALL
Expro Ltd
XPRO
$2.1B
| $56.1K | ﹤0.01% |
4,500
-3,700
| -45% | -$51.6K |
|
12228
PUT
Heartland Express
HTLD
$989M
| $56.1K | ﹤0.01% |
5,000
+900
| +22% | +$10.6K |
|
12229
T-REX 2X Long Tesla Daily Target ETF
TSLT
$161M
| $56.1K | ﹤0.01% |
1,480
-152,916
| -99% | -$4.14M |
|
12230
PUT
Eve Holding
EVEX
$951M
| $56K | ﹤0.01% |
10,300
+10,200
| +10,200% | +$38.3K |
|
12231
PUT
Alector
ALEC
$219M
| $55.9K | ﹤0.01% |
29,600
+24,900
| +530% | +$93.7K |
|
12232
PUT
Eton Pharmaceutcials
ETON
$1.68B
| $55.9K | ﹤0.01% |
4,200
+3,700
| +740% | +$37.5K |
|
12233
Mind CTI
MNDO
$20.6M
| $55.9K | ﹤0.01% |
28,394
-13,019
| -31% | -$25.7K |
|
12234
Jack Henry & Associates
JKHY
$10.9B
| $55.9K | ﹤0.01% |
319
-103,723
| -100% | -$18.5M |
|
12235
CALL
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.66B
| $55.9K | ﹤0.01% |
+4,300
| New | +$58K |
|
12236
CALL
Enanta Pharmaceuticals
ENTA
$383M
| $55.8K | ﹤0.01% |
9,700
+4,900
| +102% | +$47K |
|
|
ETHD
12237
PUT
ProShares UltraShort Ether ETF
ETHD
$63.7M
| $55.8K | ﹤0.01% |
250
+130
| +108% | +$49.6K |
|
12238
PUT
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.98B
| $55.7K | ﹤0.01% |
+1,200
| New | +$56.7K |
|
12239
CALL
Champions Oncology
CSBR
$70.4M
| $55.7K | ﹤0.01% |
+6,500
| New | +$32.7K |
|
12240
CALL
ProQR Therapeutics
PRQR
$271M
| $55.6K | ﹤0.01% |
21,000
+20,700
| +6,900% | +$65.7K |
|
12241
CALL
Afya
AFYA
$1.27B
| $55.6K | ﹤0.01% |
3,500
+1,400
| +67% | +$23.1K |
|
12242
CALL
Aware
AWRE
$26.4M
| $55.6K | ﹤0.01% |
28,500
+26,000
| +1,040% | +$44.3K |
|
12243
CALL
TXO Partners LP
TXO
$763M
| $55.6K | ﹤0.01% |
3,300
+300
| +10% | +$5.45K |
|
12244
CALL
Kite Realty
KRG
$5.3B
| $55.5K | ﹤0.01% |
2,200
-11,100
| -83% | -$292K |
|
12245
CALL
MasterBrand
MBC
$1.86B
| $55.5K | ﹤0.01% |
3,800
-13,000
| -77% | -$222K |
|
12246
Siebert Financial
SIEB
$78.9M
| $55.5K | ﹤0.01% |
17,565
+13,690
| +353% | +$37.1K |
|
12247
PUT
Fulcrum Therapeutics
FULC
$285M
| $55.5K | ﹤0.01% |
11,800
-190,400
| -94% | -$702K |
|
12248
CALL
ALX Oncology
ALXO
$271M
| $55.4K | ﹤0.01% |
33,200
-38,400
| -54% | -$59K |
|
|
TBNK
12249
DELISTED
Territorial Bancorp Inc.
TBNK
| $55.4K | ﹤0.01% |
5,692
-2,998
| -34% | -$31.6K |
|
12250
PUT
Amplify Seymour Cannabis ETF
CNBS
$76.5M
| $55.4K | ﹤0.01% |
2,250
-75
| -3% | -$3.27K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.